Sr One Capital Management as of Sept. 30, 2025
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 12 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 27.9 | $193M | 2.3M | 82.10 | |
| CRISPR Therapeutics Common Shares (CRSP) | 19.1 | $132M | 2.0M | 64.81 | |
| Zenas BioPharma Common Stock (ZBIO) | 15.8 | $109M | 4.9M | 22.20 | |
| Mineralys Therapeutics Common Stock (MLYS) | 11.6 | $80M | 2.1M | 37.92 | |
| ORIC Pharmaceuticals Common Stock (ORIC) | 7.8 | $54M | 4.5M | 12.00 | |
| Design Therapeutics Common Stock (DSGN) | 7.1 | $49M | 6.5M | 7.53 | |
| ARS Pharmaceuticals Common Stock (SPRY) | 5.8 | $40M | 4.0M | 10.05 | |
| Oruka Therapeutics Common Stock (ORKA) | 1.2 | $8.3M | 430k | 19.23 | |
| Alumis Common Stock (ALMS) | 1.1 | $7.8M | 2.0M | 3.99 | |
| Nkarta Common Stock (NKTX) | 1.0 | $6.9M | 3.3M | 2.07 | |
| Oculis Holding Ordinary Shares (OCS) | 0.8 | $5.7M | 323k | 17.58 | |
| enGene Holdings Common Shares (ENGN) | 0.7 | $5.1M | 748k | 6.83 |
